A brand new report innovation discovered that of the highest 100 most progressive firms, the most important quantity – 18 – had been from the pharmaceutical trade.

Main pharmaceutical teams together with Bristol-Myers Squibb (New York inventory market :BMY), Eli Lily (THERE IS), Johnson & Johnson (New York inventory market :JNJ), Novartis (NVS), Pfizer (New York inventory market :DFP), Rock (OTCQX: RHHBY), and Sanofi (SNY) made record, compiled by LexisNexis.

Among the many main biotechs, Amgen (AMGN), Galaad Sciences (NASDAQ:BROWN), Trendy (mrna), and Regeneron (REGN) made the reduce.

Alnylam Prescribed drugs (ALNY), which focuses on the event of RNA interference (RNAi) therapies, and Jazz Prescribed drugs (JAZZ), identified for his or her medicine for sleep issues and epilepsy, had been added in 2023.

The LexisNexis report, Innovation Momentum 2023: the World Prime 100lists firms with the strongest innovation momentum, primarily based on the Patent Asset Index, an “goal measure scientifically developed to evaluate innovation energy”.

“An growing older international inhabitants and the lengthy tail of the COVID-19 pandemic are creating demand for brand spanking new therapies and prescription drugs,” The report states. “This affords alternatives for small gamers with progressive applied sciences, but in addition for big firms.”

Among the many 18 pharmaceutical firms included within the report, 13 are primarily based in the US, the remaining in Europe.

9 medical know-how firms had been additionally included. LexisNexis famous that these firms had been in a position to enhance the scale of their patent portfolios in addition to keep or enhance the scale of these portfolios.

Whereas medtech firms have similarities when it comes to patent portfolio development and geographic areas, they differ considerably on the subject of their applied sciences.

The report notes that Medtronic (MTD) has the most important patent portfolio. Its “applied sciences allow every little thing from digital diabetes monitoring to minimally invasive surgical procedure and tiny lead-free pacemakers that may be implanted straight into the guts.”

LexisNexis stated the ResMed (MDM), identified for its ventilators and CPAP units used for sleep apnea, has seen the standard of its patents enhance in recent times because of the elevated use of its units throughout the COVID-19 pandemic.

Align Expertise (ALGN), identified for its clear tooth aligners. “By specializing in one sort of machine, he was in a position to steadily enhance the typical high quality of his patents.”

LexisNexis additionally pointed to Becton, Dickinson (BDX), Edwards Life Sciences (EO), intuitive surgical procedure (ISRG), and Stryker (SYK) than different progressive medtechs with sturdy patent portfolios.